Carisma Therapeutics Inc. Liabilities Assumed
Carisma Therapeutics Inc. reported Liabilities Assumed of $0 for the 12-month period ending 2018-12-31, per its 10-K filed 2019-03-01.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:LiabilitiesAssumed1 · last filed 2019-03-01
- Carisma Therapeutics Inc. liabilities assumed for the quarter ending 2017-12-31 was $0.00, a 100.00% decline year-over-year.
- Carisma Therapeutics Inc. liabilities assumed for the quarter ending 2016-12-31 was $6.50M.
- Carisma Therapeutics Inc. liabilities assumed for the quarter ending 2015-12-31 was $0.00.
- Carisma Therapeutics Inc. liabilities assumed for fiscal 2018 was $0.00.
- Carisma Therapeutics Inc. liabilities assumed for fiscal 2017 was $0.00, a 100.00% decline from fiscal 2016.
- Carisma Therapeutics Inc. liabilities assumed for fiscal 2016 was $19.78M.
- Carisma Therapeutics Inc. liabilities assumed for fiscal 2015 was $0.00.
| Period end | Liabilities Assumed 3 month | Liabilities Assumed 9 month | Liabilities Assumed 12 month |
|---|---|---|---|
| 2018-12-31 | $0.00 10-K · filed 2019-03-01 | ||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $0.00 10-K · filed 2019-03-01 | |
| 2017-09-30 | $0.00 10-Q · filed 2017-11-17 | ||
| 2016-12-31 | $6.50M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $19.78M 10-K · filed 2019-03-01 | |
| 2016-09-30 | $13.28M 10-Q · filed 2017-11-17 | ||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | $0.00 10-K · filed 2018-04-02 | |
| 2015-09-30 | $0.00 10-Q · filed 2016-11-14 | ||
| 2014-12-31 | $0.00 10-K · filed 2017-03-24 |